iNova Pharmaceuticals’s $13.5 million Acquisition of Probiotec’s Gold Cross, David Craig and Skin Basics brands

Arnold Bloch Leibler advised ASX-listed Probiotec Limited on the deal Probiotec executed an agreement to sell pharmaceutical brands Gold Cross, David Craig and Skin Basics, including...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Shanghai Pharmaceuticals’ Joint Venture with Phililab to Launch Its First Overseas R&D Center

Sidley has advised Shanghai Pharmaceuticals Holding Co. Ltd. (HKEX: 2607) (SSE: 601607) (SPH) on its joint venture with Phililab, Inc. (Phililab) through its Delaware subsidiary, SPH...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here